A detailed history of Two Sigma Investments, LP transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Two Sigma Investments, LP holds 257,309 shares of ENTA stock, worth $3.34 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
257,309
Previous 332,232 22.55%
Holding current value
$3.34 Million
Previous $3.13 Million 43.7%
% of portfolio
0.01%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$10.08 - $17.46 $755,223 - $1.31 Million
-74,923 Reduced 22.55%
257,309 $4.49 Million
Q4 2023

Feb 14, 2024

BUY
$8.18 - $10.78 $983,751 - $1.3 Million
120,263 Added 56.74%
332,232 $3.13 Million
Q3 2023

Nov 14, 2023

BUY
$11.09 - $22.13 $2.02 Million - $4.04 Million
182,346 Added 615.56%
211,969 $2.37 Million
Q2 2023

Aug 14, 2023

BUY
$20.68 - $39.85 $612,603 - $1.18 Million
29,623 New
29,623 $633,000
Q4 2022

Feb 14, 2023

BUY
$40.77 - $53.73 $730,679 - $962,949
17,922 Added 126.28%
32,114 $1.49 Million
Q3 2022

Nov 14, 2022

BUY
$48.29 - $71.27 $29,022 - $42,833
601 Added 4.42%
14,192 $736,000
Q2 2022

Aug 15, 2022

BUY
$38.13 - $76.93 $518,224 - $1.05 Million
13,591 New
13,591 $642,000
Q1 2022

May 16, 2022

SELL
$56.06 - $74.11 $4.64 Million - $6.13 Million
-82,682 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$60.19 - $97.37 $1.08 Million - $1.74 Million
17,904 Added 27.64%
82,682 $6.18 Million
Q3 2021

Nov 15, 2021

SELL
$41.02 - $58.65 $36,876 - $52,726
-899 Reduced 1.37%
64,778 $3.68 Million
Q2 2021

Aug 16, 2021

BUY
$43.76 - $53.11 $55,443 - $67,290
1,267 Added 1.97%
65,677 $2.89 Million
Q1 2021

May 17, 2021

SELL
$41.69 - $54.95 $34,561 - $45,553
-829 Reduced 1.27%
64,410 $3.18 Million
Q4 2020

Feb 16, 2021

BUY
$41.16 - $47.47 $752,610 - $867,988
18,285 Added 38.94%
65,239 $2.75 Million
Q3 2020

Nov 16, 2020

SELL
$43.36 - $53.53 $858,267 - $1.06 Million
-19,794 Reduced 29.65%
46,954 $2.15 Million
Q2 2020

Aug 14, 2020

SELL
$46.37 - $57.58 $1.67 Million - $2.07 Million
-35,986 Reduced 35.03%
66,748 $3.35 Million
Q1 2020

May 15, 2020

SELL
$40.22 - $62.0 $1.29 Million - $1.99 Million
-32,021 Reduced 23.76%
102,734 $5.28 Million
Q4 2019

Feb 14, 2020

BUY
$57.95 - $66.61 $3.84 Million - $4.41 Million
66,198 Added 96.56%
134,755 $8.33 Million
Q3 2019

Nov 14, 2019

BUY
$60.08 - $88.17 $571,420 - $838,584
9,511 Added 16.11%
68,557 $4.12 Million
Q2 2019

Aug 14, 2019

BUY
$81.3 - $97.35 $2.53 Million - $3.03 Million
31,150 Added 111.66%
59,046 $4.98 Million
Q1 2019

May 15, 2019

SELL
$69.08 - $105.66 $2.28 Million - $3.48 Million
-32,971 Reduced 54.17%
27,896 $2.67 Million
Q4 2018

Feb 14, 2019

BUY
$65.41 - $84.65 $2.44 Million - $3.16 Million
37,352 Added 158.84%
60,867 $4.31 Million
Q3 2018

Nov 14, 2018

BUY
$85.46 - $126.37 $2.01 Million - $2.97 Million
23,515 New
23,515 $2.01 Million
Q2 2018

Aug 14, 2018

SELL
$81.85 - $120.51 $4.44 Million - $6.54 Million
-54,295 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$57.91 - $92.15 $269,860 - $429,419
-4,660 Reduced 7.9%
54,295 $4.39 Million
Q4 2017

Feb 14, 2018

BUY
$45.65 - $59.37 $2.05 Million - $2.67 Million
45,002 Added 322.53%
58,955 $3.46 Million
Q3 2017

Nov 14, 2017

BUY
$37.91 - $46.8 $528,958 - $653,000
13,953
13,953 $653,000

Others Institutions Holding ENTA

About ENANTA PHARMACEUTICALS INC


  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $269M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.